Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
5.70
Dollar change
+0.09
Percentage change
1.60
%
IndexRUT P/E241.53 EPS (ttm)0.02 Insider Own3.30% Shs Outstand270.03M Perf Week11.11%
Market Cap1.55B Forward P/E22.98 EPS next Y0.25 Insider Trans-0.62% Shs Float263.32M Perf Month22.58%
Income8.49M PEG6.78 EPS next Q0.01 Inst Own49.35% Short Float13.02% Perf Quarter32.56%
Sales224.60M P/S6.91 EPS this Y375.00% Inst Trans8.21% Short Ratio15.15 Perf Half Y58.77%
Book/sh-0.85 P/B- EPS next Y125.45% ROA2.18% Short Interest34.28M Perf Year37.35%
Cash/sh1.10 P/C5.16 EPS next 5Y35.60% ROE- 52W Range3.17 - 5.75 Perf YTD56.59%
Dividend Est.- P/FCF538.97 EPS past 5Y40.58% ROI7.58% 52W High-0.87% Beta1.32
Dividend TTM- Quick Ratio3.57 Sales past 5Y55.42% Gross Margin70.99% 52W Low79.81% ATR (14)0.21
Dividend Ex-Date- Current Ratio3.84 EPS Y/Y TTM111.30% Oper. Margin13.79% RSI (14)69.87 Volatility3.78% 4.46%
Employees414 Debt/Eq- Sales Y/Y TTM74.92% Profit Margin3.78% Recom1.40 Target Price6.60
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q188.14% Payout- Rel Volume0.94 Prev Close5.61
Sales Surprise9.44% EPS Surprise53.85% Sales Q/Q63.10% EarningsMay 08 AMC Avg Volume2.26M Price5.70
SMA2011.11% SMA5019.31% SMA20037.57% Trades Volume2,124,161 Change1.60%
Date Action Analyst Rating Change Price Target Change
Jun-13-24Initiated Rodman & Renshaw Buy $8
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Jun-22-24 08:00AM
Jun-05-24 06:45AM
May-29-24 08:45AM
08:45AM
May-13-24 12:00PM
03:01AM Loading…
May-10-24 03:01AM
May-09-24 01:46PM
11:47AM
12:15AM
May-08-24 07:30PM
07:10PM
06:07PM
04:18PM
May-06-24 06:38AM
06:05AM
04:00PM Loading…
May-01-24 04:00PM
Apr-30-24 06:05AM
Apr-29-24 11:17AM
06:05AM
Apr-03-24 06:00AM
Mar-26-24 04:05PM
Mar-25-24 11:45AM
Mar-11-24 06:05AM
Mar-05-24 06:05AM
Mar-04-24 01:01PM
Feb-28-24 09:30AM
08:11AM
01:00AM
Feb-27-24 06:00PM
05:35PM
04:46PM Loading…
04:46PM
04:00PM
Feb-20-24 06:00AM
Feb-15-24 06:05AM
Feb-12-24 12:30PM
Jan-25-24 05:29PM
Jan-02-24 06:05AM
Dec-28-23 06:00AM
Dec-16-23 09:01PM
Nov-08-23 03:27PM
Nov-07-23 09:15PM
05:30PM
04:12PM
04:00PM
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
Oct-30-23 06:15AM
Sep-07-23 07:08AM
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
11:33AM
12:00AM
Aug-07-23 06:00PM
05:25PM
04:16PM
04:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
07:00AM
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
06:00AM
May-09-23 11:30PM
08:21PM
05:15PM
04:18PM
04:00PM
01:41PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
05:31AM
Nov-08-22 04:30PM
09:15AM
08:00AM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binder Steven B.EVP Special ProjectsMay 21 '24Sale4.6625,952120,9361,114,553May 21 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 21 '24Sale4.6623,537109,682873,616May 21 09:00 PM
Binder Steven B.EVP Special ProjectsMay 13 '24Sale4.313,61815,594845,967May 14 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 13 '24Sale4.313,04713,133783,446May 14 09:00 PM
Castagna MichaelChief Executive OfficerDec 15 '23Sale4.0090,482361,9282,148,665Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerDec 14 '23Sale4.00110,000440,0002,239,147Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerNov 01 '23Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02 '23Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01 '23Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28 '23Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01 '23Sale4.5710,00045,6862,496,735Aug 01 09:00 PM